APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global GLP-1 Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025192 pages

Choose your research edition.

Industry ResearchGLP-1 Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Drug Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal GLP-1 Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global GLP-1 Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for GLP-1 Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GLP-1 Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP-1 Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for GLP-1 Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GLP-1 Drug include AstraZeneca, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline (GSK), Hanmi Pharmaceutical Co, Novo Nordisk, Pfizer Inc, Sanofi and Teva Pharmaceutical Industries Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GLP-1 Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GLP-1 Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GLP-1 Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GLP-1 Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

GLP-1 Drug Segment by Company

AstraZeneca

Boehringer Ingelheim

Eli Lilly

GlaxoSmithKline (GSK)

Hanmi Pharmaceutical Co

Novo Nordisk

Pfizer Inc

Sanofi

Teva Pharmaceutical Industries Ltd

Gan & Lee Pharmaceuticals

Huadong Medicine

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

PegBio Co., Ltd

Shanghai Benemae Pharmaceutical Corporation

Tonghua Dongbao

GLP-1 Drug Segment by Type

Short-acting GLP-1 Drug

Long-acting GLP-1 Drug

GLP-1 Drug Segment by Application

Type 2 Diabetes (T2DM)

Alzheimer's Disease (AD)

Non-alcoholic Steatohepatitis (NASH)

Obesity

Cardiovascular and Cerebrovascular Diseases (CVD)

GLP-1 Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GLP-1 Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GLP-1 Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of GLP-1 Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of GLP-1 Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. GLP-1 Drug Industry Trends Table 2. GLP-1 Drug Industry Drivers Table 3. GLP-1 Drug Industry Opportunities and Challenges Table 4. GLP-1 Drug Industry Restraints Table 5. Global GLP-1 Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global GLP-1 Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global GLP-1 Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global GLP-1 Drug Sales Market Share by Manufacturers Table 9. Global GLP-1 Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global GLP-1 Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global GLP-1 Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global GLP-1 Drug Manufacturers, Product Type & Application Table 13. Global GLP-1 Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global GLP-1 Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Short-acting GLP-1 Drug Table 17. Major Manufacturers of Long-acting GLP-1 Drug Table 18. Global GLP-1 Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global GLP-1 Drug Sales by Type (2021-2026) & (K Units) Table 20. Global GLP-1 Drug Sales by Type (2027-2032) & (K Units) Table 21. Global GLP-1 Drug Sales Market Share by Type (2021-2026) Table 22. Global GLP-1 Drug Sales Market Share by Type (2027-2032) Table 23. Global GLP-1 Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global GLP-1 Drug Revenue by Type (2021-2026) & (K Units) Table 25. Global GLP-1 Drug Revenue by Type (2027-2032) & (K Units) Table 26. Global GLP-1 Drug Revenue Market Share by Type (2021-2026) Table 27. Global GLP-1 Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Type 2 Diabetes (T2DM) Table 29. Major Manufacturers of Alzheimer's Disease (AD) Table 30. Major Manufacturers of Non-alcoholic Steatohepatitis (NASH) Table 31. Major Manufacturers of Obesity Table 32. Major Manufacturers of Cardiovascular and Cerebrovascular Diseases (CVD) Table 33. Global GLP-1 Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global GLP-1 Drug Sales by Application (2021-2026) & (K Units) Table 35. Global GLP-1 Drug Sales by Application (2027-2032) & (K Units) Table 36. Global GLP-1 Drug Sales Market Share by Application (2021-2026) Table 37. Global GLP-1 Drug Sales Market Share by Application (2027-2032) Table 38. Global GLP-1 Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global GLP-1 Drug Revenue by Application (2021-2026) & (K Units) Table 40. Global GLP-1 Drug Revenue by Application (2027-2032) & (K Units) Table 41. Global GLP-1 Drug Revenue Market Share by Application (2021-2026) Table 42. Global GLP-1 Drug Revenue Market Share by Application (2027-2032) Table 43. Global GLP-1 Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global GLP-1 Drug Sales by Region (2021-2026) & (K Units) Table 45. Global GLP-1 Drug Sales Market Share by Region (2021-2026) Table 46. Global GLP-1 Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global GLP-1 Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America GLP-1 Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America GLP-1 Drug Sales by Country (2021-2026) & (K Units) Table 50. North America GLP-1 Drug Sales by Country (2027-2032) & (K Units) Table 51. Europe GLP-1 Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe GLP-1 Drug Sales by Country (2021-2026) & (K Units) Table 53. Europe GLP-1 Drug Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific GLP-1 Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific GLP-1 Drug Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific GLP-1 Drug Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa GLP-1 Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa GLP-1 Drug Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa GLP-1 Drug Sales by Country (2027-2032) & (K Units) Table 60. Global GLP-1 Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global GLP-1 Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global GLP-1 Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global GLP-1 Drug Revenue Market Share by Region (2021-2026) Table 64. Global GLP-1 Drug Revenue Market Share by Region (2027-2032) Table 65. AstraZeneca Company Information Table 66. AstraZeneca Business Overview Table 67. AstraZeneca GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. AstraZeneca GLP-1 Drug Product Portfolio Table 69. AstraZeneca Recent Development Table 70. Boehringer Ingelheim Company Information Table 71. Boehringer Ingelheim Business Overview Table 72. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Boehringer Ingelheim GLP-1 Drug Product Portfolio Table 74. Boehringer Ingelheim Recent Development Table 75. Eli Lilly Company Information Table 76. Eli Lilly Business Overview Table 77. Eli Lilly GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Eli Lilly GLP-1 Drug Product Portfolio Table 79. Eli Lilly Recent Development Table 80. GlaxoSmithKline (GSK) Company Information Table 81. GlaxoSmithKline (GSK) Business Overview Table 82. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolio Table 84. GlaxoSmithKline (GSK) Recent Development Table 85. Hanmi Pharmaceutical Co Company Information Table 86. Hanmi Pharmaceutical Co Business Overview Table 87. Hanmi Pharmaceutical Co GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolio Table 89. Hanmi Pharmaceutical Co Recent Development Table 90. Novo Nordisk Company Information Table 91. Novo Nordisk Business Overview Table 92. Novo Nordisk GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Novo Nordisk GLP-1 Drug Product Portfolio Table 94. Novo Nordisk Recent Development Table 95. Pfizer Inc Company Information Table 96. Pfizer Inc Business Overview Table 97. Pfizer Inc GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Pfizer Inc GLP-1 Drug Product Portfolio Table 99. Pfizer Inc Recent Development Table 100. Sanofi Company Information Table 101. Sanofi Business Overview Table 102. Sanofi GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Sanofi GLP-1 Drug Product Portfolio Table 104. Sanofi Recent Development Table 105. Teva Pharmaceutical Industries Ltd Company Information Table 106. Teva Pharmaceutical Industries Ltd Business Overview Table 107. Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolio Table 109. Teva Pharmaceutical Industries Ltd Recent Development Table 110. Gan & Lee Pharmaceuticals Company Information Table 111. Gan & Lee Pharmaceuticals Business Overview Table 112. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolio Table 114. Gan & Lee Pharmaceuticals Recent Development Table 115. Huadong Medicine Company Information Table 116. Huadong Medicine Business Overview Table 117. Huadong Medicine GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Huadong Medicine GLP-1 Drug Product Portfolio Table 119. Huadong Medicine Recent Development Table 120. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information Table 121. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Business Overview Table 122. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolio Table 124. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Development Table 125. PegBio Co., Ltd Company Information Table 126. PegBio Co., Ltd Business Overview Table 127. PegBio Co., Ltd GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. PegBio Co., Ltd GLP-1 Drug Product Portfolio Table 129. PegBio Co., Ltd Recent Development Table 130. Shanghai Benemae Pharmaceutical Corporation Company Information Table 131. Shanghai Benemae Pharmaceutical Corporation Business Overview Table 132. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolio Table 134. Shanghai Benemae Pharmaceutical Corporation Recent Development Table 135. Tonghua Dongbao Company Information Table 136. Tonghua Dongbao Business Overview Table 137. Tonghua Dongbao GLP-1 Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Tonghua Dongbao GLP-1 Drug Product Portfolio Table 139. Tonghua Dongbao Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. GLP-1 Drug Distributors List Table 143. GLP-1 Drug Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. GLP-1 Drug Product Image Figure 2. Global GLP-1 Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global GLP-1 Drug Sales (2021-2032) & (K Units) Figure 5. Global GLP-1 Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 GLP-1 Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Short-acting GLP-1 Drug Image Figure 9. Long-acting GLP-1 Drug Image Figure 10. Global GLP-1 Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global GLP-1 Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global GLP-1 Drug Sales Market Share by Type (2021-2032) Figure 13. Global GLP-1 Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global GLP-1 Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global GLP-1 Drug Revenue Market Share by Type (2021-2032) Figure 16. Type 2 Diabetes (T2DM) Image Figure 17. Alzheimer's Disease (AD) Image Figure 18. Non-alcoholic Steatohepatitis (NASH) Image Figure 19. Obesity Image Figure 20. Cardiovascular and Cerebrovascular Diseases (CVD) Image Figure 21. Global GLP-1 Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global GLP-1 Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global GLP-1 Drug Sales Market Share by Application (2021-2032) Figure 24. Global GLP-1 Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global GLP-1 Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global GLP-1 Drug Revenue Market Share by Application (2021-2032) Figure 27. North America GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America GLP-1 Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe GLP-1 Drug Sales Market Share by Country (2021-2032) Figure 34. Germany GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific GLP-1 Drug Sales Market Share by Country (2021-2032) Figure 41. China GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa GLP-1 Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile GLP-1 Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global GLP-1 Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global GLP-1 Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America GLP-1 Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America GLP-1 Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe GLP-1 Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe GLP-1 Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific GLP-1 Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific GLP-1 Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa GLP-1 Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa GLP-1 Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. GLP-1 Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. GLP-1 Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Short-acting GLP-1 Drug
  • Long-acting GLP-1 Drug
Applications
  • Type 2 Diabetes (T2DM)
  • Alzheimer's Disease (AD)
  • Non-alcoholic Steatohepatitis (NASH)
  • Obesity
  • Cardiovascular and Cerebrovascular Diseases (CVD)
Companies covered
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly
  • GlaxoSmithKline (GSK)
  • Hanmi Pharmaceutical Co
  • Novo Nordisk
  • Pfizer Inc
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • Gan & Lee Pharmaceuticals
  • Huadong Medicine
  • Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
  • PegBio Co., Ltd
  • Shanghai Benemae Pharmaceutical Corporation
  • Tonghua Dongbao

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global GLP-1 Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global GLP-1 Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global GLP-1 Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global GLP-1 Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global GLP-1 Drug Market Dynamics
  1. 2.1 GLP-1 Drug Industry Trends
  2. 2.2 GLP-1 Drug Industry Drivers
  3. 2.3 GLP-1 Drug Industry Opportunities and Challenges
  4. 2.4 GLP-1 Drug Industry Restraints
3 GLP-1 Drug Market by Manufacturers
  1. 3.1 Global GLP-1 Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global GLP-1 Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global GLP-1 Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global GLP-1 Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GLP-1 Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global GLP-1 Drug Manufacturers, Product Type & Application
  7. 3.7 Global GLP-1 Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GLP-1 Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GLP-1 Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GLP-1 Drug Tier 1, Tier 2, and Tier 3
4 GLP-1 Drug Market by Type
  1. 4.1 GLP-1 Drug Type Introduction
  2. 4.1.1 Short-acting GLP-1 Drug
  3. 4.1.2 Long-acting GLP-1 Drug
  4. 4.2 Global GLP-1 Drug Sales by Type
  5. 4.2.1 Global GLP-1 Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global GLP-1 Drug Sales by Type (2021-2032)
  7. 4.2.3 Global GLP-1 Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global GLP-1 Drug Revenue by Type
  9. 4.3.1 Global GLP-1 Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global GLP-1 Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global GLP-1 Drug Revenue Market Share by Type (2021-2032)
5 GLP-1 Drug Market by Application
  1. 5.1 GLP-1 Drug Application Introduction
  2. 5.1.1 Type 2 Diabetes (T2DM)
  3. 5.1.2 Alzheimer's Disease (AD)
  4. 5.1.3 Non-alcoholic Steatohepatitis (NASH)
  5. 5.1.4 Obesity
  6. 5.1.5 Cardiovascular and Cerebrovascular Diseases (CVD)
  7. 5.2 Global GLP-1 Drug Sales by Application
  8. 5.2.1 Global GLP-1 Drug Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global GLP-1 Drug Sales by Application (2021-2032)
  10. 5.2.3 Global GLP-1 Drug Sales Market Share by Application (2021-2032)
  11. 5.3 Global GLP-1 Drug Revenue by Application
  12. 5.3.1 Global GLP-1 Drug Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global GLP-1 Drug Revenue by Application (2021-2032)
  14. 5.3.3 Global GLP-1 Drug Revenue Market Share by Application (2021-2032)
6 Global GLP-1 Drug Sales by Region
  1. 6.1 Global GLP-1 Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GLP-1 Drug Sales by Region (2021-2032)
  3. 6.2.1 Global GLP-1 Drug Sales by Region (2021-2026)
  4. 6.2.2 Global GLP-1 Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America GLP-1 Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America GLP-1 Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe GLP-1 Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe GLP-1 Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific GLP-1 Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific GLP-1 Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa GLP-1 Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa GLP-1 Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global GLP-1 Drug Revenue by Region
  1. 7.1 Global GLP-1 Drug Revenue by Region
  2. 7.1.1 Global GLP-1 Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global GLP-1 Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global GLP-1 Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global GLP-1 Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America GLP-1 Drug Revenue (2021-2032)
  8. 7.2.2 North America GLP-1 Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe GLP-1 Drug Revenue (2021-2032)
  11. 7.3.2 Europe GLP-1 Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific GLP-1 Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific GLP-1 Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa GLP-1 Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa GLP-1 Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca GLP-1 Drug Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim GLP-1 Drug Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly GLP-1 Drug Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 GlaxoSmithKline (GSK)
  20. 8.4.1 GlaxoSmithKline (GSK) Company Information
  21. 8.4.2 GlaxoSmithKline (GSK) Business Overview
  22. 8.4.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolio
  24. 8.4.5 GlaxoSmithKline (GSK) Recent Developments
  25. 8.5 Hanmi Pharmaceutical Co
  26. 8.5.1 Hanmi Pharmaceutical Co Company Information
  27. 8.5.2 Hanmi Pharmaceutical Co Business Overview
  28. 8.5.3 Hanmi Pharmaceutical Co GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolio
  30. 8.5.5 Hanmi Pharmaceutical Co Recent Developments
  31. 8.6 Novo Nordisk
  32. 8.6.1 Novo Nordisk Company Information
  33. 8.6.2 Novo Nordisk Business Overview
  34. 8.6.3 Novo Nordisk GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novo Nordisk GLP-1 Drug Product Portfolio
  36. 8.6.5 Novo Nordisk Recent Developments
  37. 8.7 Pfizer Inc
  38. 8.7.1 Pfizer Inc Company Information
  39. 8.7.2 Pfizer Inc Business Overview
  40. 8.7.3 Pfizer Inc GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Inc GLP-1 Drug Product Portfolio
  42. 8.7.5 Pfizer Inc Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi GLP-1 Drug Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
  49. 8.9 Teva Pharmaceutical Industries Ltd
  50. 8.9.1 Teva Pharmaceutical Industries Ltd Company Information
  51. 8.9.2 Teva Pharmaceutical Industries Ltd Business Overview
  52. 8.9.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolio
  54. 8.9.5 Teva Pharmaceutical Industries Ltd Recent Developments
  55. 8.10 Gan & Lee Pharmaceuticals
  56. 8.10.1 Gan & Lee Pharmaceuticals Company Information
  57. 8.10.2 Gan & Lee Pharmaceuticals Business Overview
  58. 8.10.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolio
  60. 8.10.5 Gan & Lee Pharmaceuticals Recent Developments
  61. 8.11 Huadong Medicine
  62. 8.11.1 Huadong Medicine Company Information
  63. 8.11.2 Huadong Medicine Business Overview
  64. 8.11.3 Huadong Medicine GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Huadong Medicine GLP-1 Drug Product Portfolio
  66. 8.11.5 Huadong Medicine Recent Developments
  67. 8.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
  68. 8.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
  69. 8.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Business Overview
  70. 8.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolio
  72. 8.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments
  73. 8.13 PegBio Co., Ltd
  74. 8.13.1 PegBio Co., Ltd Company Information
  75. 8.13.2 PegBio Co., Ltd Business Overview
  76. 8.13.3 PegBio Co., Ltd GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 PegBio Co., Ltd GLP-1 Drug Product Portfolio
  78. 8.13.5 PegBio Co., Ltd Recent Developments
  79. 8.14 Shanghai Benemae Pharmaceutical Corporation
  80. 8.14.1 Shanghai Benemae Pharmaceutical Corporation Company Information
  81. 8.14.2 Shanghai Benemae Pharmaceutical Corporation Business Overview
  82. 8.14.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolio
  84. 8.14.5 Shanghai Benemae Pharmaceutical Corporation Recent Developments
  85. 8.15 Tonghua Dongbao
  86. 8.15.1 Tonghua Dongbao Company Information
  87. 8.15.2 Tonghua Dongbao Business Overview
  88. 8.15.3 Tonghua Dongbao GLP-1 Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Tonghua Dongbao GLP-1 Drug Product Portfolio
  90. 8.15.5 Tonghua Dongbao Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GLP-1 Drug Value Chain Analysis
  2. 9.1.1 GLP-1 Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GLP-1 Drug Production Mode & Process
  6. 9.2 GLP-1 Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GLP-1 Drug Distributors
  9. 9.2.3 GLP-1 Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst